1. Liver toxicity as a limiting factor to the increasing use of immune checkpoint inhibitors;De Martin;JHEP Rep Innov Hepatol,2020
2. Management of toxicities from immunotherapy: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up;Haanen;Ann Oncol Off J Eur Soc Med Oncol,2022
3. Management of Immune-Related Adverse Events in Patients Treated With Immune Checkpoint Inhibitor Therapy: ASCO Guideline Update;Schneider;J Clin Oncol,2021
4. Clinical pattern of checkpoint inhibitor-induced liver injury in a multicentre cohort;Hountondji;JHEP Rep,2023
5. Immune Checkpoint Inhibitor Rechallenge After Immune-Related Adverse Events in Patients With Cancer;Dolladille;JAMA Oncol,2020